Serum Exosomal Long Noncoding RNA Growth Arrest-Specific 5 Predicts 3-Month Mortality in Acute-on-Chronic Hepatitis B Liver Failure
Cheng-Xi Sun,Li-Yan Han,Kai Wang,Shuai Gao
DOI: https://doi.org/10.2147/jir.s423321
IF: 4.5
2023-10-17
Journal of Inflammation Research
Abstract:Cheng-Xi Sun, 1 Li-Yan Han, 2, 3 Kai Wang, 2, 3 Shuai Gao 2, 3 1 Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China; 2 Department of Hepatology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China; 3 Institute of Hepatology, Shandong University, Jinan, Shandong, 250012, People's Republic of China Correspondence: Shuai Gao, Department of Hepatology, Qilu Hospital of Shandong University, No. 107, Wenhuaxi Road, Jinan, Shandong, 250012, People's Republic of China, Tel +86-531-82169593, Fax +86-531-86927544, Email ; Background: Acute-on-chronic hepatitis B liver failure (ACHBLF) is a clinical syndrome with an extremely high mortality. In this study, we aim to evaluate the potential role of serum exosomal long noncoding RNA (lncRNA) growth arrest-specific 5 (GAS5) in ACHBLF and its predictive value for 3-month mortality. Methods: From December 2017 to June 2022, we enrolled 110 patients with ACHBLF and 42 healthy controls (HCs). Exosomes were isolated from the serum of the participants. Serum exosomal lncRNA GAS5 was detected using quantitative real-time polymerase chain reaction (qRT-PCR). The functional role of lncRNA GAS5 on hepatocyte phenotypes was investigated through loss-of-function and gain-of-function assays. Exosomal labeling and cell uptake assay were used to determine the exosomes-mediated transmission of lncRNA GAS5 in hepatocytes in vitro. Results: The serum exosomal lncRNA GAS5 was identified to be an independent predictor for 3-month mortality of ACHBLF. It yielded an area under the receiver operating characteristic curve (AUC) of 0.88, which was significantly higher than MELD score (AUC 0.73; P < 0.01). Further study found that lncRNA GAS5 could inhibit hepatocytes proliferation and increase hepatocytes apoptosis. Exosomes-mediated lncRNA GAS5 transfer promoted hepatocytes injury. The knocked down of lncRNA GAS5 weakened H 2 O 2 -induced hepatocytes injury. Conclusion: We revealed that serum exosomal lncRNA GAS5 might promote hepatocytes injury and showed high predictive value for 3-month mortality in ACHBLF. Keywords: acute-on-chronic hepatitis B liver failure, exosomes, long noncoding RNA, growth arrest-specific 5, prognosis Acute-on-chronic liver failure (ACLF) is a complex clinical syndrome characterized by an acute episode of liver dysfunction in patients with pre-existing chronic liver diseases. 1,2 The common causes of ACLF include viral infection, bacterial infection, alcoholic hepatitis and surgery injury. 1,3–5 In Asia, hepatitis B virus (HBV) infection remains the main cause of ACLF, which is named acute-on-chronic hepatitis B liver failure (ACHBLF). The short-term mortality of ACHBLF is as high as 63%–72.3%. 2 Until now, liver transplantation remains the only determined cure for ACHBLF. However, it is hard to be applied widely due to the limitation of liver donors and high cost in most Asia countries. Therefore, prognostic biomarkers for ACHBLF are urgently needed. Exosomes are nanosized vesicles with a diameter of 40–200 nm, which can serve as mediators of intercellular communication through transferring proteins, nucleic acids and lipids among cells. 6 Recent studies revealed that exosomes participated in the development and progression of several kinds of liver diseases. 7–9 Long noncoding RNAs (lncRNAs) refer to a class of non-protein coding transcripts with a length of more than 200 nucleotides. 10 They can regulate gene expression at the transcriptional and post-transcriptional levels through interacting with DNA, RNA or proteins. 11 Recently, emerging evidences suggested that lncRNAs encapsulated in exosomes were involved in regulating physiological and pathological processes, such as immune response, inflammation, tumor growth and infection. 12,13 In our previous study, we found that the serum exosomal lncRNA NEAT1 was aberrantly overexpressed in ACHBLF and might serve as a biomarker for short-term prognosis of ACHBLF. 14 LncRNA growth arrest-specific transcript 5 (GAS5) has been proven to inhibit cells growth and sensitize cells to apoptosis. 15,16 Low level of lncRNA GAS5 was found to be associated with early recurrence and poor prognosis of non-muscle-invasive bladder cancer. 17 The up-regulated lncRNA GAS5 inhibited glioma cell growth, migration and invasion. 18 Upregulation of lncRNA GAS5 suppressed cell proliferation, promoted cell apoptosis and reversed the resistance of cells to EGFR-TKIs via downregulation of the IGF-1R expression.<s -Abstract Truncated-
immunology